Fundraising FoxVcgt
Kobe, JP · Founded 2020 · 1 known investors
Find your way into Vcgt
Sign up to see every warm intro you have to Vcgt
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vcgt team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
VC Gene Therapy develops gene therapies, with a first pipeline using genome editing to treat autosomal dominant inherited retinal degenerative diseases and aiming to begin clinical trials. It is a subsidiary of Vision Care Inc. and part of the Vision Care Group, based in Kobe, Japan.
Founders & leadership
Vcgt was founded in 2020 by Masashiro Takahashi.
MT
Masashiro Takahashi
TF
Takuma FukudaDirector & CFO (取締役 CFO)
YN
Yoshinori NishikawaAuditor (監査役)
Board
YI
Yuji InomataDirector (取締役)
TC
Tsuyoshi ChiwataOutside Director (社外取締役)
Investors · 1
Frequently asked questions
- What does Vcgt do?
- VC Gene Therapy develops gene therapies, with a first pipeline using genome editing to treat autosomal dominant inherited retinal degenerative diseases and aiming to begin clinical trials. It is a subsidiary of Vision Care Inc. and part of the Vision Care Group, based in Kobe, Japan.
- Who founded Vcgt?
- Vcgt was founded by Masashiro Takahashi in 2020.
- Who are Vcgt's investors?
- Vcgt's investors include Kobe University Capital.
- Where is Vcgt headquartered?
- Vcgt is headquartered in Kobe, JP.